Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis

Objective Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. Background Amyloid‐β (Aβ) or tau‐focused clinical trials hav...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2022-11, Vol.18 (11), p.2327-2340
Hauptverfasser: Lecca, Daniela, Jung, Yoo Jin, Scerba, Michael T., Hwang, Inho, Kim, Yu Kyung, Kim, Sun, Modrow, Sydney, Tweedie, David, Hsueh, Shih‐Chang, Liu, Dong, Luo, Weiming, Glotfelty, Elliot, Li, Yazhou, Wang, Jia‐Yi, Luo, Yu, Hoffer, Barry J., Kim, Dong Seok, McDevitt, Ross A., Greig, Nigel H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2340
container_issue 11
container_start_page 2327
container_title Alzheimer's & dementia
container_volume 18
creator Lecca, Daniela
Jung, Yoo Jin
Scerba, Michael T.
Hwang, Inho
Kim, Yu Kyung
Kim, Sun
Modrow, Sydney
Tweedie, David
Hsueh, Shih‐Chang
Liu, Dong
Luo, Weiming
Glotfelty, Elliot
Li, Yazhou
Wang, Jia‐Yi
Luo, Yu
Hoffer, Barry J.
Kim, Dong Seok
McDevitt, Ross A.
Greig, Nigel H.
description Objective Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. Background Amyloid‐β (Aβ) or tau‐focused clinical trials have proved unsuccessful in mitigating AD‐associated cognitive impairment. Identification of new drug targets is needed. Neuroinflammation is a therapeutic target in neurodegenerative disorders, and TNF‐α a pivotal neuroinflammatory driver. New hypothesis AD‐associated chronic neuroinflammation directly drives progressive synaptic/neuronal loss and cognitive decline. Pharmacologically mitigating microglial/astrocyte activation without altering Aβ generation will define the role of neuroinflammation in AD progression. Major challenges Difficulty of TNF‐α‐lowering compounds reaching brain, and identification of a therapeutic‐time window to preserve the beneficial role of neuroinflammatory processes. Linkage to other major theories Microglia/astroglia are heavily implicated in maintenance of synaptic plasticity/function in healthy brain and are disrupted by Aβ. Mitigation of chronic gliosis can restore synaptic homeostasis/cognitive function.
doi_str_mv 10.1002/alz.12610
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_455126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2635245309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4530-ceb32099dce550d90994199d9b0650c108bbcfe940e657c1ed5d84ae6c971f893</originalsourceid><addsrcrecordid>eNp1kcFO3DAQhq0KVCj00BeofIRDYJzY2TUHpNWqpZVWQkLtgV4sx5mwbh17iRPQ9unxkmUFB04ez3z-Z8Y_IV8YnDGA_Fy7_2csLxl8IIdMiDwT-UTu7eISDsinGP8CcJgy8ZEcFCIveFHwQ3J7ExzS0FCz7IK3hnocumB943Tb6t4GT60fkyunY2-N7ddU-5qacOdtbx-QNoM3G_KCzuhyvQr9EqONx2S_0S7i5-15RH5___Zr_iNbXF_9nM8WmeGigMxgVeQgZW1QCKhlCjlLV1lBKcAwmFaVaVBywFJMDMNa1FOusTRywpqpLI5INurGR1wNlVp1ttXdWgVt1Tb1L0WouBDpkxJ_OfKp0mJq6_tOuzfP3la8Xaq78KAkLyaMQxI42Qp04X7A2KvWRoPOaY9hiCr1EPlmt81spyNquhBjh82uDQO1sU4l69SzdYn9-nquHfniVQLOR-DROly_r6Rmiz-j5BOFdaXo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2635245309</pqid></control><display><type>article</type><title>Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SWEPUB Freely available online</source><creator>Lecca, Daniela ; Jung, Yoo Jin ; Scerba, Michael T. ; Hwang, Inho ; Kim, Yu Kyung ; Kim, Sun ; Modrow, Sydney ; Tweedie, David ; Hsueh, Shih‐Chang ; Liu, Dong ; Luo, Weiming ; Glotfelty, Elliot ; Li, Yazhou ; Wang, Jia‐Yi ; Luo, Yu ; Hoffer, Barry J. ; Kim, Dong Seok ; McDevitt, Ross A. ; Greig, Nigel H.</creator><creatorcontrib>Lecca, Daniela ; Jung, Yoo Jin ; Scerba, Michael T. ; Hwang, Inho ; Kim, Yu Kyung ; Kim, Sun ; Modrow, Sydney ; Tweedie, David ; Hsueh, Shih‐Chang ; Liu, Dong ; Luo, Weiming ; Glotfelty, Elliot ; Li, Yazhou ; Wang, Jia‐Yi ; Luo, Yu ; Hoffer, Barry J. ; Kim, Dong Seok ; McDevitt, Ross A. ; Greig, Nigel H.</creatorcontrib><description>Objective Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. Background Amyloid‐β (Aβ) or tau‐focused clinical trials have proved unsuccessful in mitigating AD‐associated cognitive impairment. Identification of new drug targets is needed. Neuroinflammation is a therapeutic target in neurodegenerative disorders, and TNF‐α a pivotal neuroinflammatory driver. New hypothesis AD‐associated chronic neuroinflammation directly drives progressive synaptic/neuronal loss and cognitive decline. Pharmacologically mitigating microglial/astrocyte activation without altering Aβ generation will define the role of neuroinflammation in AD progression. Major challenges Difficulty of TNF‐α‐lowering compounds reaching brain, and identification of a therapeutic‐time window to preserve the beneficial role of neuroinflammatory processes. Linkage to other major theories Microglia/astroglia are heavily implicated in maintenance of synaptic plasticity/function in healthy brain and are disrupted by Aβ. Mitigation of chronic gliosis can restore synaptic homeostasis/cognitive function.</description><identifier>ISSN: 1552-5260</identifier><identifier>ISSN: 1552-5279</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.12610</identifier><identifier>PMID: 35234334</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>3,6’‐dithioPomalidomide ; 5xFAD mice ; Alzheimer Disease ; Alzheimer pathology ; Amyloid beta-Peptides ; amyloid hypothesis ; Animals ; Cognition ; Cognitive Dysfunction ; Disease Models, Animal ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Microglia ; microglial/astrocyte activation ; neuroinflammation ; Neuroinflammatory Diseases ; Neuronal Plasticity ; TNF‐α ; Tumor Necrosis Factor-alpha</subject><ispartof>Alzheimer's &amp; dementia, 2022-11, Vol.18 (11), p.2327-2340</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This article has been contributed to by US Government employees and their work is in the public domain in the USA.</rights><rights>2022 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. This article has been contributed to by US Government employees and their work is in the public domain in the USA.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4530-ceb32099dce550d90994199d9b0650c108bbcfe940e657c1ed5d84ae6c971f893</citedby><cites>FETCH-LOGICAL-c4530-ceb32099dce550d90994199d9b0650c108bbcfe940e657c1ed5d84ae6c971f893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Falz.12610$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Falz.12610$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35234334$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:148977607$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Lecca, Daniela</creatorcontrib><creatorcontrib>Jung, Yoo Jin</creatorcontrib><creatorcontrib>Scerba, Michael T.</creatorcontrib><creatorcontrib>Hwang, Inho</creatorcontrib><creatorcontrib>Kim, Yu Kyung</creatorcontrib><creatorcontrib>Kim, Sun</creatorcontrib><creatorcontrib>Modrow, Sydney</creatorcontrib><creatorcontrib>Tweedie, David</creatorcontrib><creatorcontrib>Hsueh, Shih‐Chang</creatorcontrib><creatorcontrib>Liu, Dong</creatorcontrib><creatorcontrib>Luo, Weiming</creatorcontrib><creatorcontrib>Glotfelty, Elliot</creatorcontrib><creatorcontrib>Li, Yazhou</creatorcontrib><creatorcontrib>Wang, Jia‐Yi</creatorcontrib><creatorcontrib>Luo, Yu</creatorcontrib><creatorcontrib>Hoffer, Barry J.</creatorcontrib><creatorcontrib>Kim, Dong Seok</creatorcontrib><creatorcontrib>McDevitt, Ross A.</creatorcontrib><creatorcontrib>Greig, Nigel H.</creatorcontrib><title>Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis</title><title>Alzheimer's &amp; dementia</title><addtitle>Alzheimers Dement</addtitle><description>Objective Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. Background Amyloid‐β (Aβ) or tau‐focused clinical trials have proved unsuccessful in mitigating AD‐associated cognitive impairment. Identification of new drug targets is needed. Neuroinflammation is a therapeutic target in neurodegenerative disorders, and TNF‐α a pivotal neuroinflammatory driver. New hypothesis AD‐associated chronic neuroinflammation directly drives progressive synaptic/neuronal loss and cognitive decline. Pharmacologically mitigating microglial/astrocyte activation without altering Aβ generation will define the role of neuroinflammation in AD progression. Major challenges Difficulty of TNF‐α‐lowering compounds reaching brain, and identification of a therapeutic‐time window to preserve the beneficial role of neuroinflammatory processes. Linkage to other major theories Microglia/astroglia are heavily implicated in maintenance of synaptic plasticity/function in healthy brain and are disrupted by Aβ. Mitigation of chronic gliosis can restore synaptic homeostasis/cognitive function.</description><subject>3,6’‐dithioPomalidomide</subject><subject>5xFAD mice</subject><subject>Alzheimer Disease</subject><subject>Alzheimer pathology</subject><subject>Amyloid beta-Peptides</subject><subject>amyloid hypothesis</subject><subject>Animals</subject><subject>Cognition</subject><subject>Cognitive Dysfunction</subject><subject>Disease Models, Animal</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Microglia</subject><subject>microglial/astrocyte activation</subject><subject>neuroinflammation</subject><subject>Neuroinflammatory Diseases</subject><subject>Neuronal Plasticity</subject><subject>TNF‐α</subject><subject>Tumor Necrosis Factor-alpha</subject><issn>1552-5260</issn><issn>1552-5279</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNp1kcFO3DAQhq0KVCj00BeofIRDYJzY2TUHpNWqpZVWQkLtgV4sx5mwbh17iRPQ9unxkmUFB04ez3z-Z8Y_IV8YnDGA_Fy7_2csLxl8IIdMiDwT-UTu7eISDsinGP8CcJgy8ZEcFCIveFHwQ3J7ExzS0FCz7IK3hnocumB943Tb6t4GT60fkyunY2-N7ddU-5qacOdtbx-QNoM3G_KCzuhyvQr9EqONx2S_0S7i5-15RH5___Zr_iNbXF_9nM8WmeGigMxgVeQgZW1QCKhlCjlLV1lBKcAwmFaVaVBywFJMDMNa1FOusTRywpqpLI5INurGR1wNlVp1ttXdWgVt1Tb1L0WouBDpkxJ_OfKp0mJq6_tOuzfP3la8Xaq78KAkLyaMQxI42Qp04X7A2KvWRoPOaY9hiCr1EPlmt81spyNquhBjh82uDQO1sU4l69SzdYn9-nquHfniVQLOR-DROly_r6Rmiz-j5BOFdaXo</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Lecca, Daniela</creator><creator>Jung, Yoo Jin</creator><creator>Scerba, Michael T.</creator><creator>Hwang, Inho</creator><creator>Kim, Yu Kyung</creator><creator>Kim, Sun</creator><creator>Modrow, Sydney</creator><creator>Tweedie, David</creator><creator>Hsueh, Shih‐Chang</creator><creator>Liu, Dong</creator><creator>Luo, Weiming</creator><creator>Glotfelty, Elliot</creator><creator>Li, Yazhou</creator><creator>Wang, Jia‐Yi</creator><creator>Luo, Yu</creator><creator>Hoffer, Barry J.</creator><creator>Kim, Dong Seok</creator><creator>McDevitt, Ross A.</creator><creator>Greig, Nigel H.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>202211</creationdate><title>Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis</title><author>Lecca, Daniela ; Jung, Yoo Jin ; Scerba, Michael T. ; Hwang, Inho ; Kim, Yu Kyung ; Kim, Sun ; Modrow, Sydney ; Tweedie, David ; Hsueh, Shih‐Chang ; Liu, Dong ; Luo, Weiming ; Glotfelty, Elliot ; Li, Yazhou ; Wang, Jia‐Yi ; Luo, Yu ; Hoffer, Barry J. ; Kim, Dong Seok ; McDevitt, Ross A. ; Greig, Nigel H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4530-ceb32099dce550d90994199d9b0650c108bbcfe940e657c1ed5d84ae6c971f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3,6’‐dithioPomalidomide</topic><topic>5xFAD mice</topic><topic>Alzheimer Disease</topic><topic>Alzheimer pathology</topic><topic>Amyloid beta-Peptides</topic><topic>amyloid hypothesis</topic><topic>Animals</topic><topic>Cognition</topic><topic>Cognitive Dysfunction</topic><topic>Disease Models, Animal</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Microglia</topic><topic>microglial/astrocyte activation</topic><topic>neuroinflammation</topic><topic>Neuroinflammatory Diseases</topic><topic>Neuronal Plasticity</topic><topic>TNF‐α</topic><topic>Tumor Necrosis Factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lecca, Daniela</creatorcontrib><creatorcontrib>Jung, Yoo Jin</creatorcontrib><creatorcontrib>Scerba, Michael T.</creatorcontrib><creatorcontrib>Hwang, Inho</creatorcontrib><creatorcontrib>Kim, Yu Kyung</creatorcontrib><creatorcontrib>Kim, Sun</creatorcontrib><creatorcontrib>Modrow, Sydney</creatorcontrib><creatorcontrib>Tweedie, David</creatorcontrib><creatorcontrib>Hsueh, Shih‐Chang</creatorcontrib><creatorcontrib>Liu, Dong</creatorcontrib><creatorcontrib>Luo, Weiming</creatorcontrib><creatorcontrib>Glotfelty, Elliot</creatorcontrib><creatorcontrib>Li, Yazhou</creatorcontrib><creatorcontrib>Wang, Jia‐Yi</creatorcontrib><creatorcontrib>Luo, Yu</creatorcontrib><creatorcontrib>Hoffer, Barry J.</creatorcontrib><creatorcontrib>Kim, Dong Seok</creatorcontrib><creatorcontrib>McDevitt, Ross A.</creatorcontrib><creatorcontrib>Greig, Nigel H.</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lecca, Daniela</au><au>Jung, Yoo Jin</au><au>Scerba, Michael T.</au><au>Hwang, Inho</au><au>Kim, Yu Kyung</au><au>Kim, Sun</au><au>Modrow, Sydney</au><au>Tweedie, David</au><au>Hsueh, Shih‐Chang</au><au>Liu, Dong</au><au>Luo, Weiming</au><au>Glotfelty, Elliot</au><au>Li, Yazhou</au><au>Wang, Jia‐Yi</au><au>Luo, Yu</au><au>Hoffer, Barry J.</au><au>Kim, Dong Seok</au><au>McDevitt, Ross A.</au><au>Greig, Nigel H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2022-11</date><risdate>2022</risdate><volume>18</volume><issue>11</issue><spage>2327</spage><epage>2340</epage><pages>2327-2340</pages><issn>1552-5260</issn><issn>1552-5279</issn><eissn>1552-5279</eissn><abstract>Objective Evaluating the efficacy of 3,6’‐dithioPomalidomide in 5xFAD Alzheimer's disease (AD) mice to test the hypothesis that neuroinflammation is directly involved in the development of synaptic/neuronal loss and cognitive decline. Background Amyloid‐β (Aβ) or tau‐focused clinical trials have proved unsuccessful in mitigating AD‐associated cognitive impairment. Identification of new drug targets is needed. Neuroinflammation is a therapeutic target in neurodegenerative disorders, and TNF‐α a pivotal neuroinflammatory driver. New hypothesis AD‐associated chronic neuroinflammation directly drives progressive synaptic/neuronal loss and cognitive decline. Pharmacologically mitigating microglial/astrocyte activation without altering Aβ generation will define the role of neuroinflammation in AD progression. Major challenges Difficulty of TNF‐α‐lowering compounds reaching brain, and identification of a therapeutic‐time window to preserve the beneficial role of neuroinflammatory processes. Linkage to other major theories Microglia/astroglia are heavily implicated in maintenance of synaptic plasticity/function in healthy brain and are disrupted by Aβ. Mitigation of chronic gliosis can restore synaptic homeostasis/cognitive function.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>35234334</pmid><doi>10.1002/alz.12610</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2022-11, Vol.18 (11), p.2327-2340
issn 1552-5260
1552-5279
1552-5279
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_455126
source MEDLINE; Wiley Online Library Journals Frontfile Complete; SWEPUB Freely available online
subjects 3,6’‐dithioPomalidomide
5xFAD mice
Alzheimer Disease
Alzheimer pathology
Amyloid beta-Peptides
amyloid hypothesis
Animals
Cognition
Cognitive Dysfunction
Disease Models, Animal
Mice
Mice, Inbred C57BL
Mice, Transgenic
Microglia
microglial/astrocyte activation
neuroinflammation
Neuroinflammatory Diseases
Neuronal Plasticity
TNF‐α
Tumor Necrosis Factor-alpha
title Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T04%3A36%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20chronic%20neuroinflammation%20in%20neuroplasticity%20and%20cognitive%20function:%20A%20hypothesis&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Lecca,%20Daniela&rft.date=2022-11&rft.volume=18&rft.issue=11&rft.spage=2327&rft.epage=2340&rft.pages=2327-2340&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.12610&rft_dat=%3Cproquest_swepu%3E2635245309%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2635245309&rft_id=info:pmid/35234334&rfr_iscdi=true